NPI 1548429566: Open Payments
NPI 1548429566. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 10 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $71 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Exact Sciences Corporation | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
Products named: FREESTYLE LIBRE 3, GEMTESA, Cologuard Collection Kit, VOQUEZNA.
